1287 related articles for article (PubMed ID: 30644982)
1. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
[TBL] [Abstract][Full Text] [Related]
2. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
3. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
[TBL] [Abstract][Full Text] [Related]
4. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
[TBL] [Abstract][Full Text] [Related]
7. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
[TBL] [Abstract][Full Text] [Related]
8. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Pandit NG; Zaman M; Minkoff NZ; Tanner-Smith EE; Gomez-Duarte OG; Acra S; Nicholson MR
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD012774. PubMed ID: 37094824
[TBL] [Abstract][Full Text] [Related]
9. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
[TBL] [Abstract][Full Text] [Related]
11. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial.
Lahtinen P; Jalanka J; Mattila E; Tillonen J; Bergman P; Satokari R; Arkkila P
World J Gastroenterol; 2023 May; 29(17):2666-2678. PubMed ID: 37213403
[TBL] [Abstract][Full Text] [Related]
13. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study.
Sood A; Mahajan R; Singh A; Midha V; Mehta V; Narang V; Singh T; Singh Pannu A
J Crohns Colitis; 2019 Sep; 13(10):1311-1317. PubMed ID: 30873549
[TBL] [Abstract][Full Text] [Related]
14. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Mourad FH; Francis FF; Binion DG; Farraye FA; Hashash JG
Inflamm Bowel Dis; 2023 May; 29(5):808-817. PubMed ID: 35766805
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
Narula N; Kassam Z; Yuan Y; Colombel JF; Ponsioen C; Reinisch W; Moayyedi P
Inflamm Bowel Dis; 2017 Oct; 23(10):1702-1709. PubMed ID: 28906291
[TBL] [Abstract][Full Text] [Related]
18. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
[TBL] [Abstract][Full Text] [Related]
19. Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
Stallmach A; Grunert P; Stallhofer J; Löffler B; Baier M; Rödel J; Kiehntopf M; Neugebauer S; Pieper DH; Junca H; Tannapfel A; Merkel U; Schumacher U; Breternitz-Gruhne M; Heller T; Schauer A; Hartmann M; Steube A
Trials; 2022 Feb; 23(1):173. PubMed ID: 35193638
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
Kunde S; Pham A; Bonczyk S; Crumb T; Duba M; Conrad H; Cloney D; Kugathasan S
J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):597-601. PubMed ID: 23542823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]